Inhibitory B7-family molecules in the tumour microenvironment

Inflammation and cancer

Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111 · see citing works

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · see citing works

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294 · see citing works

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151 · see citing works

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025 · see citing works

Restoring function in exhausted CD8 T cells during chronic viral infection

Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 3,960 · see citing works

Tumour-educated macrophages promote tumour progression and metastasis

Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,365 · see citing works

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., & Minato, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192461099 · Cited by 3,204 · see citing works

CELLULAR RESPONSES TO INTERFERON-γ

Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · see citing works

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680 · see citing works

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669 · see citing works

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496 · see citing works

Cancer and the chemokine network

Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · see citing works

Ido expression by dendritic cells: tolerance and tryptophan catabolism

Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341 · see citing works

Regulatory T cells, tumour immunity and immunotherapy

Zou, W. (2006) · Nature reviews. Immunology · doi:10.1038/nri1806 · Cited by 2,075 · see citing works

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057 · see citing works

Reciprocal Control of T Helper Cell and Dendritic Cell Differentiation

Rissoan, M., Soumelis, V., Kadowaki, N., Grouard, G., Brière, F., Malefyt, R. D. W., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.283.5405.1183 · Cited by 1,835 · see citing works

Regulation of immune responses by L-arginine metabolism

Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775 · see citing works

Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses

Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,733 · see citing works

The B7–CD28 superfamily

Sharpe, A. H., & Freeman, G. J. (2002) · Nature reviews. Immunology · doi:10.1038/nri727 · Cited by 1,713 · see citing works

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565 · see citing works

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 ⁺ T lymphocytes are prognostic factors of human ovarian cancer

Hamanishi, J., Mandai, M., Iwasaki, M., Okazaki, T., Tanaka, Y., Yamaguchi, K., Higuchi, T., Yagi, H., Takakura, K., Minato, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611533104 · Cited by 1,378 · see citing works

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

Parsa, A. T., Waldron, J. S., Panner, A., Crane, C. A., Parney, I. F., Barry, J. J., Cachola, K. E., Murray, J. C., Tihan, T., Jensen, M. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1517 · Cited by 1,341 · see citing works

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314 · see citing works

Tissue expression of PD-L1 mediates peripheral T cell tolerance

Keir, M., Liang, S. C., Guleria, I., Latchman, Y., Qipo, A., Albacker, L., Koulmanda, M., Freeman, G., Sayegh, M., & Sharpe, A. (2006) · Journal of Experimental Medicine · doi:10.1084/jem.20051776 · Cited by 1,264 · see citing works

Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity

Chen, L. (2004) · Nature reviews. Immunology · doi:10.1038/nri1349 · Cited by 1,257 · see citing works

Dendritic cells as therapeutic vaccines against cancer

Banchereau, J., & Palucka, A. K. (2005) · Nature reviews. Immunology · doi:10.1038/nri1592 · Cited by 1,195 · see citing works

A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors

Wyckoff, J. B., Wang, W., Lin, E. Y., Wang, Y., Pixley, F. J., Stanley, E. R., Graf, T., Pollard, J. W., Segall, J. E., & Condeelis, J. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1449 · Cited by 1,189 · see citing works

Natural selection of tumor variants in the generation of “tumor escape” phenotypes

Khong, H. T., & Restifo, N. P. (2002) · Nature Immunology · doi:10.1038/ni1102-999 · Cited by 1,058 · see citing works

Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase

Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R. E., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028 · see citing works

Mechanisms and functional significance of tumour-induced dendritic-cell defects

Gabrilovich, D. I. (2004) · Nature reviews. Immunology · doi:10.1038/nri1498 · Cited by 1,022 · see citing works

Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity

Hirano, F., Kaneko, K., Tamura, H., Dong, H., Wang, S., Ichikawa, M., Rietz, C., Flies, D. B., Lau, J. S., Zhu, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.1089.65.3 · Cited by 1,018 · see citing works

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

Brown, J. A., Dorfman, D. M., Ma, F.-R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A., & Freeman, G. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1257 · Cited by 968 · see citing works

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

Melero, I., Shuford, W. W., Newby, S. A., Aruffo, A. A., Ledbetter, J. A., Hellström, K. E., Mittler, R. S., & Chen, L. (1997) · Nature Medicine · doi:10.1038/nm0697-682 · Cited by 899 · see citing works

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L., Schacker, T., Roederer, M., Douek, D. C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061496 · Cited by 889 · see citing works

Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer

Nomi, T., Sho, M., Akahori, T., Hamada, K., Kubo, A., Kanehiro, H., Nakamura, S., Enomoto, K., Yagita, H., Azuma, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2746 · Cited by 889 · see citing works

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., et al. (2003) · Nature Immunology · doi:10.1038/ni944 · Cited by 883 · see citing works

Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up

Thompson, R. H., Kuntz, S. M., Leibovich, B. C., Dong, H., Lohse, C. M., Webster, W. S., Sengupta, S., Frank, I., Parker, A. S., Zincke, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4303 · Cited by 869 · see citing works

The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice

Ansari, M. J., Salama, A. D., Chitnis, T., Smith, R. N., Yagita∥, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022125 · Cited by 806 · see citing works

Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer

Ohigashi, Y., Sho, M., Yamada, Y., Tsurui, Y., Hamada, K., Ikeda, N., Mizuno, T., Yoriki, R., Kashizuka, H., Yane, K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1469 · Cited by 796 · see citing works

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

Sharma, M. D., Baban, B., Chandler, P., Hou, D., Singh, N., Yagita∥, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 791 · see citing works

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

Thompson, R. H., Gillett, M. D., Cheville, J. C., Lohse, C. M., Dong, H., Webster, W. S., Krejci, K. G., Lobo, J. R., Sengupta, S., Chen, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406351101 · Cited by 776 · see citing works

PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells

Blank, C., Brown, I., Peterson, A. C., Spiotto, M., Iwai, Y., Honjo, T., & Gajewski, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3259 · Cited by 772 · see citing works

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050930 · Cited by 748 · see citing works

Does the Immune System See Tumors as Foreign or Self?

Pardoll, D. M. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141135 · Cited by 746 · see citing works

Infections as a major preventable cause of human cancer

Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740 · see citing works

B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity

Sica, G., Choi, I.-H., Zhu, G., Tamada, K., Wang, S.-D., Tamura, H., Chapoval, A. I., Flies, D. B., Bajorath, J., & Chen, L. (2003) · Immunity · doi:10.1016/s1074-7613(03)00152-3 · Cited by 709 · see citing works

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway

Augello, A., Tasso, R., Negrini, S. M., Amateis, A., Indiveri, F., Cancedda, R., & Pennesi, G. (2005) · European Journal of Immunology · doi:10.1002/eji.200425405 · Cited by 697 · see citing works

Inflammation and necrosis promote tumour growth

Vakkila, J., & Lotze, M. T. (2004) · Nature reviews. Immunology · doi:10.1038/nri1415 · Cited by 692 · see citing works

Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism

Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 692 · see citing works

B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 Expression

Konishi, J. S., Yamazaki, K., Azuma, M., Kinoshita, I., Dosaka‐Akita, H., & Nishimura, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0428 · Cited by 678 · see citing works

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

Zou, W., Machelon, V., L’Herminé, A. C., Borvak, J., Mercier‐Nomé, F., Isaeva, T., Wei, S., Krzysiek, R., Durand–Gasselin, I., Gordon, A. N., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1339 · Cited by 653 · see citing works

Cancer vaccines: between the idea and the reality

Finn, O. J. (2003) · Nature reviews. Immunology · doi:10.1038/nri1150 · Cited by 635 · see citing works

B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

Šedý, J. R., Gavrieli, M., Potter, K. G., Hurchla, M. A., Lindsley, R. C., Hildner, K. M., Scheu, S., Pfeffer, K., Ware, C. F., Murphy, T. L., et al. (2004) · Nature Immunology · doi:10.1038/ni1144 · Cited by 633 · see citing works

PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells

Latchman, Y. E., Liang, S. C., Wu, Y., Chernova, T., Sobel, R. A., Klemm, M., Kuchroo, V. K., Freeman, G. J., & Sharpe, A. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307252101 · Cited by 631 · see citing works

The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic Factors

Ghebeh, H., Mohammed, S. F., Al-Omair, A., Qattan, A. T., Lehé, C. L., Al-Qudaihi, G., Elkum, N. B., Alshabanah, M., Amer, S. M. B., Tulbah, A. M., et al. (2006) · Neoplasia · doi:10.1593/neo.05733 · Cited by 612 · see citing works

Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-γ and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway

Liu, J., Hamrouni, A., Wołowiec, D., Coiteux, V., Kuliczkowski, K., Hétuin, D., Saudemont, A., & Quesnel, B. (2007) · Blood · doi:10.1182/blood-2006-10-051482 · Cited by 580 · see citing works

Checkpoint Blockade in Cancer Immunotherapy

Korman, A. J., Peggs, K. S., & Allison, J. P. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)90008-x · Cited by 577 · see citing works

Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4

Probst, H. C., McCoy, K. D., Okazaki, T., Honjo, T., & van den Broek, M. F. (2005) · Nature Immunology · doi:10.1038/ni1165 · Cited by 554 · see citing works

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

Azuma, T., Yao, S., Zhu, G., Flies, A. S., Flies, S. J., & Chen, L. (2008) · Blood · doi:10.1182/blood-2007-11-123141 · Cited by 528 · see citing works

PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells

Iwai, Y. (2004) · International Immunology · doi:10.1093/intimm/dxh194 · Cited by 527 · see citing works

Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes

Romero, P. J., Dunbar, P. R., Valmori, D., Pittet, M. J., Ogg, G. S., Rimoldi, D., Chen, J., Líénard, D., Cerottini, J., & Cerundolo, V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1641 · Cited by 521 · see citing works

Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance

Wu, C., Zhu, Y., Jiang, J., Zhao, J., Zhang, X., & Xu, N. (2006) · Acta Histochemica · doi:10.1016/j.acthis.2006.01.003 · Cited by 492 · see citing works

B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.

Strome, S. E., Dong, H., Tamura, H., Voss, S. G., Flies, D. B., Tamada, K., Salomão, D. R., Cheville, J. C., Hirano, F., Lin, W. Y., et al. (2003) · PubMed · Cited by 489 · see citing works

Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers

Nakanishi, J., Wada, Y., Matsumoto, K., Azuma, M., Kikuchi, K., & Ueda, S. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0266-z · Cited by 473 · see citing works

PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomata: Associations with localized stage progression

Inman, B. A., Sebo, T. J., Frigola, X., Dong, H., Bergstralh, E. J., Frank, I., Fradet, Y., Lacombe, L., & Kwon, E. D. (2007) · Cancer · doi:10.1002/cncr.22588 · Cited by 438 · see citing works

B7S1, a Novel B7 Family Member that Negatively Regulates T Cell Activation

Prasad, D. V. R., Richards, S., Muoi, X., & Dong, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00147-x · Cited by 431 · see citing works

Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma

Yang, Z., Novak, A. J., Stenson, M. J., Witzig, T. E., & Ansell, S. M. (2006) · Blood · doi:10.1182/blood-2005-08-3376 · Cited by 419 · see citing works

Mast Cells Enhance T Cell Activation: Importance of Mast Cell Costimulatory Molecules and Secreted TNF

Nakae, S., Suto, H., Iikura, M., Kakurai, M., Sedgwick, J. D., Tsai, M. M., & Galli, S. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2238 · Cited by 412 · see citing works

B7x: A widely expressed B7 family member that inhibits T cell activation

Zang, X., Loke, P., Kim, J., MURPHY, K. M. M., Waitz, R., & Allison, J. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1434299100 · Cited by 401 · see citing works

A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse

Schnütgen, F., Doerflinger, N., Calleja, C., Wendling, O., Chambon, P., & Ghyselinck, N. B. (2003) · Nature Biotechnology · doi:10.1038/nbt811 · Cited by 401 · see citing works

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

Zang, X., Thompson, R. H., Al-Ahmadie, H. A., Serio, A. M., Reuter, V. E., Eastham, J. A., Scardino, P. T., Sharma, P., & Allison, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709802104 · Cited by 401 · see citing works

PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis

Mühlbauer, M., Fleck, M., Schütz, C., Weiss, T., Froh, M., Blank, C., Schölmerich, J., & Hellerbrand, C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.007 · Cited by 378 · see citing works

B7-H1 Determines Accumulation and Deletion of Intrahepatic CD8+ T Lymphocytes

Dong, H., Zhu, G., Tamada, K., Flies, D. B., van Deursen, J. M. A., & Chen, L. (2004) · Immunity · doi:10.1016/s1074-7613(04)00050-0 · Cited by 370 · see citing works

Expression of the B7 - related molecule B7 - H1 by glioma cells: a potential mechanism of immune paralysis

Wintterle, Schreiner, Mitsdoerffer, Schneider, Chen, Meyermann, Weller, M., & Wiendl (2003) · 中国神经肿瘤杂志 · Cited by 366 · see citing works

Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation

Kusmartsev, S. A., Yu, L., & Chen, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.779 · Cited by 355 · see citing works

Regulatory T-cell compartmentalization and trafficking

Wei, S., Kryczek, I., & Zou, W. (2006) · Blood · doi:10.1182/blood-2006-01-0177 · Cited by 347 · see citing works

Relationship between B7-H4, Regulatory T Cells, and Patient Outcome in Human Ovarian Carcinoma

Kryczek, I., Wei, S., Zhu, G., Myers, L., Mottram, P. J., Cheng, P. J., Chen, L., Coukos, G., & Zou, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1866 · Cited by 336 · see citing works

B7-H1 Is Expressed by Human Endothelial Cells and Suppresses T Cell Cytokine Synthesis

Mazanet, M. M., & Hughes, C. C. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3581 · Cited by 326 · see citing works

Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway

Fife, B. T., Guleria, I., Bupp, M. G., Eagar, T. N., Tang, Q., Bour-Jordan, H., Yagita∥, H., Azuma, M., Sayegh, M. H., & Bluestone, J. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061577 · Cited by 325 · see citing works

B7-H3 and B7-H4 expression in non-small-cell lung cancer

Sun, Y., Wang, Y., Zhao, J., Gu, M., Giscombe, R., Lefvert, A. K., & Wang, X. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.05.012 · Cited by 313 · see citing works

B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival

Krambeck, A. E., Thompson, R. H., Dong, H., Lohse, C. M., Park, E. S., Kuntz, S. M., Leibovich, B. C., Blute, M. L., Cheville, J. C., & Kwon, E. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600937103 · Cited by 304 · see citing works

Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses <i>in vitro</i>

Blank, C., Kuball, J., Voelkl, S., Wiendl, H., Becker, B., Walter, B., Majdic, O., Gajewski, T. F., Theobald, M., Andreesen, R., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21775 · Cited by 297 · see citing works

Molecular Modeling and Functional Mapping of B7-H1 and B7-DC Uncouple Costimulatory Function from PD-1 Interaction

Wang, S., Bajorath, J., Flies, D. B., Dong, H., Honjo, T., & Chen, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021752 · Cited by 288 · see citing works

Cutting Edge: Induction of B7-H4 on APCs through IL-10: Novel Suppressive Mode for Regulatory T Cells

Kryczek, I., Wei, S., Zou, L., Zhu, G., Mottram, P. J., Xu, H., Chen, L., & Zou, W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.40 · Cited by 278 · see citing works

Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis

Schreiner, B., Mitsdoerffer, M., Kieseier, B. C., Chen, L., Hartung, H.-P., Weller, M., & Wiendl, H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.06.013 · Cited by 276 · see citing works

Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis.

Wintterle, S., Schreiner, B., Mitsdoerffer, M., Schneider, D., Chen, L., Meyermann, R., Weller, M., & Wiendl, H. (2003) · PubMed · Cited by 271 · see citing works

The promise of cancer vaccines

Gilboa, E. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1359 · Cited by 266 · see citing works

Dendritic Cells Infiltrating Human Non-Small Cell Lung Cancer Are Blocked at Immature Stage

Perrot, I., Blanchard, D., Freymond, N., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2763 · Cited by 266 · see citing works

B7-H1 (Programmed Death-1 Ligand) on Dendritic Cells Is Involved in the Induction and Maintenance of T Cell Anergy

Selenko-Gebauer, N., Majdic, O., Szekeres, A., Höfler, G., Guthann, E., Korthäuer, U., Zlabinger, G. J., Steinberger, P., Pickl, W. F., Stockinger, H. S. J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3637 · Cited by 261 · see citing works

Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells

Nazareth, M. R., Broderick, L., Simpson-Abelson, M. R., Kelleher, R. J., Yokota, S. J., & Bankert, R. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5552 · Cited by 259 · see citing works

A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator

Gonzalez, L. C., Loyet, K. M., Calemine-Fenaux, J., Chauhan, V., Wranik, B. J., Ouyang, W., & Eaton, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409071102 · Cited by 252 · see citing works

Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family

Choi, I.-H., Zhu, G., Sica, G., Strome, S. E., Cheville, J. C., Lau, J. S., Zhu, Y., Flies, D. B., Tamada, K., & Chen, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4650 · Cited by 244 · see citing works

Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy

Tsushima, F., Yao, S., Shin, T., Flies, A. S., Flies, S. J., Xu, H., Tamada, K., Pardoll, D. M., & Chen, L. (2007) · Blood · doi:10.1182/blood-2006-11-060087 · Cited by 237 · see citing works

Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs

Wong, R. M. S., Scotland, R., Lau, R., Wang, C., Korman, A. J., Kast, W. M., & Weber, J. S. (2007) · International Immunology · doi:10.1093/intimm/dxm091 · Cited by 229 · see citing works

B7-H4 Is Highly Expressed in Ductal and Lobular Breast Cancer

Tringler, B., Zhuo, S., Pilkington, G. R., Torkko, K. C., Singh, M., Lucia, M. S., Heinz, D. E., Papkoff, J., & Shroyer, K. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1658 · Cited by 219 · see citing works

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation

Salceda, S., Tang, T., Kmet, M., Munteanu, A. I., Ghosh, M., Macina, R. A., Liu, W., Pilkington, G. R., & Papkoff, J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.01.018 · Cited by 215 · see citing works

B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts

Hori, J., Wang, M., Miyashita, M., Tanemoto, K., Takahashi, H., Takemori, T., Okumura, K., Yagita, H., & Azuma, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5928 · Cited by 208 · see citing works

Dendritic cells: a journey from laboratory to clinic

Cerundolo, V., Hermans, I. F., & Salio, M. (2003) · Nature Immunology · doi:10.1038/ni0104-7 · Cited by 196 · see citing works

B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer

Simón, I., Zhuo, S., Corral, L. G., Diamandis, E. P., Sarno, M., Wolfert, R. L., & Kim, N. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-3550 · Cited by 191 · see citing works

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis

Dong, H., Strome, S. E., Matteson, E. L., Moder, K. G., Flies, D. B., Zhu, G., Tamura, H., Driscoll, C. L. W., & Chen, L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16015 · Cited by 188 · see citing works

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

Goldberg, M. V., Maris, C. H., Hipkiss, E. L., Flies, A. S., Zhen, L., Tuder, R. M., Grosso, J. F., Harris, T., Getnet, D., Whartenby, K. A., et al. (2007) · Blood · doi:10.1182/blood-2006-12-062422 · Cited by 187 · see citing works

In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis

Saudemont, A., & Quesnel, B. (2004) · Blood · doi:10.1182/blood-2004-01-0064 · Cited by 178 · see citing works

Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma

Thompson, R. H., Gillett, M. D., Cheville, J. C., Lohse, C. M., Dong, H., Webster, W. S., Chen, L., Zincke, H., Blute, M. L., Leibovich, B. C., et al. (2005) · Cancer · doi:10.1002/cncr.21470 · Cited by 174 · see citing works

Attenuating Lymphocyte Activity

Compaan, D. M., Gonzalez, L. C., Tom, I., Loyet, K. M., Eaton, D., & Hymowitz, S. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507629200 · Cited by 170 · see citing works

Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation

Kanai∥, T., Totsuka, T., Uraushihara, K., Makita, S., Nakamura, T., Koganei, K., Fukushima, T., Akiba, H., Yagita∥, H., Okumura, K., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4156 · Cited by 170 · see citing works

Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection

Subudhi, S. K., Zhou, P., Yerian, L. M., Chin, R., Lo, J. C., Anders, R. A., Sun, Y., Chen, L., Wang, Y., Alegre, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19210 · Cited by 161 · see citing works

IFN-γ mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy

Berner, V. K., Liu, H., Zhou, Q., Alderson, K. L., Sun, K., Weiss, J. M., Back, T. C., Longo, D. L., Blazar, B. R., Wiltrout, R. H., et al. (2007) · Nature Medicine · doi:10.1038/nm1554 · Cited by 159 · see citing works

B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression

Trabattoni, D. (2002) · Blood · doi:10.1182/blood-2002-10-3065 · Cited by 159 · see citing works

Tumor-Infiltrating Macrophages Induce Apoptosis in Activated CD8+ T Cells by a Mechanism Requiring Cell Contact and Mediated by Both the Cell-Associated Form of TNF and Nitric Oxide

Saio, M., Radoja, S., Marino, M., & Frey, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5583 · Cited by 157 · see citing works

Cutting Edge: Murine Vascular Endothelium Activates and Induces the Generation of Allogeneic CD4+25+Foxp3+ Regulatory T Cells

Krupnick, A. S., Gelman, A. E., Barchet, W., Richardson, S., Kreisel, F. H. C., Turka, L. A., Colonna, M., Patterson, G. A., & Kreisel, D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6265 · Cited by 157 · see citing works

In Vivo Immune Modulatory Activity of Hepatic Stellate Cells in Mice

Chen, C.-H., Kuo, L.-M., Chang, Y., Wu, W., Goldbach, C., Ross, M. A., Stolz, D. B., Chen, L., Fung, J. J., Lu, L., et al. (2006) · Hepatology · doi:10.1002/hep.21379 · Cited by 154 · see citing works

B7-H4 overexpression in ovarian tumors

Tringler, B., Liu, W., Corral, L. G., Torkko, K. C., Enomoto, T., Davidson, S. A., Lucia, M. S., Heinz, D. E., Papkoff, J., & Shroyer, K. R. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.08.060 · Cited by 148 · see citing works

Prospects for adoptive T cell therapy

Yee, C., Riddell, S. R., & Greenberg, P. D. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80052-0 · Cited by 134 · see citing works

NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells

Saudemont, A., Jouy, N., Hétuin, D., & Quesnel, B. (2004) · Blood · doi:10.1182/blood-2004-09-3458 · Cited by 131 · see citing works

Immunodominance and tumor escape

Schreiber, H. W., Wu, T. H., Nachman, J. B., & Kast, W. M. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0401 · Cited by 117 · see citing works

B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration

Miyatake, T., Tringler, B., Liu, W., et al. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.03.039 · Cited by 117 · see citing works

Differential Role of Programmed Death-Ligand 1 and Programmed Death-Ligand 2 in Regulating the Susceptibility and Chronic Progression of Experimental Autoimmune Encephalomyelitis

Zhu, B., Guleria, I., Khosroshahi, A., Chitnis, T., Imitola, J., Azuma, M., Yagita∥, H., Sayegh, M. H., & Khoury, S. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3480 · Cited by 115 · see citing works

Expression of the Programmed Death Ligand 1, B7-H1, on Gastric Epithelial Cells afterHelicobacter pyloriExposure Promotes Development of CD4+CD25+FoxP3+Regulatory T Cells

Beswick, E. J., Pinchuk, I. V., Das, S., Powell, D. W., & Reyes, V. E. (2007) · Infection and Immunity · doi:10.1128/iai.00553-07 · Cited by 110 · see citing works

B7 Family Molecules: Novel Immunomodulators at the Maternal-Fetal Interface

Petroff, M. G., Chen, L., Phillips, T. A., & Hunt, J. S. (2002) · Placenta · doi:10.1053/plac.2002.0813 · Cited by 110 · see citing works

Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: Identification of novel molecular biomarkers for early diagnosis and therapy

Bignotti, E., Tassi, R. A., Calza, S., et al. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.03.056 · Cited by 107 · see citing works

Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma

Tsushima, F., Tanaka, K., Otsuki, N., Youngnak‐Piboonratanakit, P., Iwai, H., Omura, K., & Azuma, M. (2005) · Oral Oncology · doi:10.1016/j.oraloncology.2005.07.013 · Cited by 106 · see citing works

New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines

Maeurer, M. J., Storkus, W. J., Kirkwood, J. M., et al. (1996) · Melanoma Research · doi:10.1097/00008390-199602000-00003 · Cited by 105 · see citing works

HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD‐1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma

Geng, H., Zhang, G., Han, X., Yuan, Y., Li, D., Zhang, H., Qiu, H., He, Y., & Feng, Z. (2006) · International Journal of Cancer · doi:10.1002/ijc.21795 · Cited by 79 · see citing works

Generation and Characterization of B7-H4/B7S1/B7x-Deficient Mice

Suh, W., Wang, S., Duncan, G. S., Miyazaki, Y., Cates, E. C., Walker, T. D., Gajewska, B., Deenick, E. K., Dawicki, W., Okada, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00755-06 · Cited by 76 · see citing works

Targeting Molecular and Cellular Inhibitory Mechanisms for Improvement of Antitumor Memory Responses Reactivated by Tumor Cell Vaccine

Webster, W. S., Thompson, R. H., Harris, K. J., Frigola, X., Kuntz, S. M., Inman, B. A., & Dong, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2860 · Cited by 73 · see citing works

Tumor-Induced Immune Suppression ofIn vivoEffector T-Cell Priming Is Mediated by the B7-H1/PD-1 Axis and Transforming Growth Factor β

Wei, S., Shreiner, A. B., Takeshita, N., Chen, L., Zou, W., & Chang, A. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6598 · Cited by 67 · see citing works

PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+cytotoxic T cells

Waeckerle‐Men, Y., Starke, A., & Wüthrich, R. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl818 · Cited by 65 · see citing works

Intrahepatic expression of the co‐stimulatory molecules programmed death‐1, and its ligands in autoimmune liver disease

Oikawa, T., Takahashi, H., Ishikawa, T., Hokari, A., Otsuki, N., Azuma, M., Zeniya, M., & Tajiri, H. (2007) · Pathology International · doi:10.1111/j.1440-1827.2007.02129.x · Cited by 58 · see citing works

Immune Signatures of Murine and Human Cancers Reveal Unique Mechanisms of Tumor Escape and New Targets for Cancer Immunotherapy

Sadun, R. E., Sachsman, S. M., Chen, X., Christenson, K., Morris, W. Z., Hu, P., & Epstein, A. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0016 · Cited by 56 · see citing works

Immune system versus tumor: shifting the balance in favor of DCs and effective immunity

Kaufman, H. L., & Disis, M. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21148 · Cited by 52 · see citing works

The role of leukemia-derived B7-H1 (PD-L1) in tumor–T-cell interactions in humans

Salih, H. R., Wintterle, S., Krusch, M., Kroner, A., Huang, Y.-H., Chen, L., & Wiendl, H. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.03.006 · Cited by 49 · see citing works

B7‐H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL‐10 levels

Geng, L., Jiang, G., Fang, Y. H., Dong, S., Xie, H., Chen, Y., Shen, M., & Zheng, S. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00746.x · Cited by 41 · see citing works

Antibody‐mediated signaling through PD‐1 costimulates T cells and enhances CD28‐dependent proliferation

del Rio, M., Penuelas‐Rivas, G., Domínguez‐Perles, R., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200535232 · Cited by 27 · see citing works

Melanoma immunotherapy: new dreams or solid hopes?

Maio, M., & Parmiani, G. (1996) · Immunology Today · doi:10.1016/0167-5699(96)30014-5 · Cited by 16 · see citing works

The blockade of immune checkpoints in cancer immunotherapy

Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · see citing works

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer

Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945 · see citing works

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

Fehrenbacher, L., Spira, A., Ballinger, M., Kowanetz, M., Vansteenkiste, J., Mazieres, J., Park, K., Smith, D., Artal-Cortes, A., Lewanski, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00587-0 · Cited by 2,756 · see citing works

CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition

Buchbinder, E. I., & Desai, A. (2016) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000239 · Cited by 2,360 · see citing works

PD-L1 expression as a predictive biomarker in cancer immunotherapy

Patel, S. P., & Kurzrock, R. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0983 · Cited by 2,291 · see citing works

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy

Peng, D., Kryczek, I., Nagarsheth, N., Zhao, L., Wei, S., Wang, W., Sun, Y., Zhao, E., Vatan, L., Szeliga, W., et al. (2015) · Nature · doi:10.1038/nature15520 · Cited by 1,201 · see citing works

Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2

Yokosuka, T., Takamatsu, M., Kobayashi-Imanishi, W., Hashimoto-Tane, A., Azuma, M., & Saito, T. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112741 · Cited by 1,161 · see citing works

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study

Powles, T., O'Donnell, P. H., Massard, C., Arkenau, H.-T., Friedlander, T. W., Hoimes, C. J., Lee, J. L., Ong, M., Sridhar, S. S., Vogelzang, N. J., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2411 · Cited by 869 · see citing works

Tumor-infiltrating NY-ESO-1–specific CD8 ⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

Matsuzaki, J., Gnjatic, S., Mhawech-Fauceglia, P., Beck, A., Miller, A., Tsuji, T., Eppolito, C., Qian, F., Lele, S., Shrikant, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003345107 · Cited by 859 · see citing works

Safety and efficacy of durvalumab (MEDI4736), an anti–programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer

Massard, C., Gordon, M. S., Sharma, S., Rafii, S., Wainberg, Z. A., Luke, J., Curiel, T. J., Colon-Otero, G., Hamid, O., Sanborn, R. E., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.9761 · Cited by 840 · see citing works

A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells

Barsoum, I. B., Smallwood, C. A., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0992 · Cited by 767 · see citing works

T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment

Crespo, J., Sun, H., Welling, T. H., Tian, Z., & Zou, W. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.003 · Cited by 752 · see citing works

PDL1 Regulation by p53 via miR-34

Cortez, M. A., Ivan, C., Valdecanas, D., Wang, X., Peltier, H. J., Ye, Y., Araujo, L., Carbone, D. P., Shilo, K., Giri, D. K., et al. (2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv303 · Cited by 683 · see citing works

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

Yang, H., Bueso-Ramos, C., DiNardo, C., Estecio, M. R., Davanlou, M., Geng, Q.-R., Fang, Z., Nguyen, M., Pierce, S., Wei, Y., et al. (2014) · Leukemia · doi:10.1038/leu.2013.355 · Cited by 688 · see citing works

Cancer immunotherapy—immune checkpoint blockade and associated endocrinopathies.

Byun, D. J., Wolchok, J. D., Rosenberg, L. M., & Girotra, M. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.205 · Cited by 685 · see citing works

Tumor-repopulating cells induce PD-1 expression in CD8(+) T cells by transferring kynurenine and AhR activation

Liu, Y., Liang, X., Dong, W., Fang, Y., Lv, J., Zhang, T., Fiskesund, R., Xie, J., Liu, J., Yin, X., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.005 · Cited by 535 · see citing works

Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma

Li, H., Wu, K., Tao, K., Chen, L., Zheng, Q., Lu, X., Liu, J., Shi, L., Liu, C., Wang, G., et al. (2012) · Hepatology · doi:10.1002/hep.25777 · Cited by 496 · see citing works

The emerging role of epigenetic therapeutics in immuno-oncology

Topper, M. J., Vaz, M., Marrone, K. A., Brahmer, J. R., & Baylin, S. B. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0266-5 · Cited by 433 · see citing works

Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions

Wu, K., Kryczek, I., Chen, L., Zou, W., & Welling, T. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0901 · Cited by 380 · see citing works

PD-1hi identifies a novel regulatory b-cell population in human hepatoma that promotes disease progression

Xiao, X., Lao, X.-M., Chen, M.-M., Liu, R.-X., Wei, Y., Ouyang, F.-Z., Chen, D.-P., Zhao, X.-Y., Zhao, Q., Li, X.-F., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1408 · Cited by 352 · see citing works

The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia

Williams, P., Basu, S., Garcia‐Manero, G., Hourigan, C. S., Oetjen, K. A., Cortes, J. E., Ravandi, F., Jabbour, E. J., Al‐Hamal, Z., Konopleva, M., et al. (2019) · Cancer · doi:10.1002/cncr.31896 · Cited by 330 · see citing works

Chemotherapy induces enrichment of CD47 ⁺ /CD73 ⁺ /PDL1 ⁺ immune evasive triple-negative breast cancer cells

Samanta, D., Park, Y., Ni, X., Li, H., Zahnow, C. A., Gabrielson, E., Pan, F., & Semenza, G. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718197115 · Cited by 302 · see citing works

PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer

Song, M., Chen, D., Lu, B., Wang, C., Zhang, J., Huang, L., Wang, X., Timmons, C. L., Hu, J., Liu, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065821 · Cited by 266 · see citing works

Characterizing the molecular regulation of inhibitory immune checkpoints with multimodal single-cell screens

Papalexi, E., Mimitou, E. P., Butler, A. W., Foster, S., Bracken, B., Mauck, W. M., Wessels, H.-H., Hao, Y., Yeung, B. Z., Smibert, P., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00778-2 · Cited by 238 · see citing works

Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

Deng, J., Li, J., Sarde, A., Lines, J. L., Lee, Y.-C., Qian, D. C., Pechenick, D. A., Manivanh, R., Le Mercier, I., Lowrey, C. H., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0507 · Cited by 224 · see citing works

CAR T-cell therapy in hematologic malignancies: a voyage in progress.

Holstein, S. A., & Lunning, M. A. (2020) · Clinical Pharmacology &amp; Therapeutics · doi:10.1002/cpt.1674 · Cited by 172 · see citing works

Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients

Tang, B., Yan, X., Sheng, X., Si, L., Cui, C., Kong, Y., Mao, L., Lian, B., Bai, X., Wang, X., et al. (2019) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-018-0693-2 · Cited by 169 · see citing works

Dual biological effects of the cytokines interleukin-10 and interferon-γ

Wilke, C. M., Wei, S., Wang, L., Kryczek, I., Kao, J., & Zou, W. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1104-5 · Cited by 138 · see citing works

Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer

Salvi, S., Fontana, V., Boccardo, S., Merlo, D. F., Margallo, E., Laurent, S., Morabito, A., Rijavec, E., Dal Bello, M. G., Mora, M., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1211-y · Cited by 133 · see citing works

Immunotherapy comes of age: Immune aging &amp; checkpoint inhibitors

Elias, R., Karantanos, T., Sira, E., & Hartshorn, K. L. (2017) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2017.02.001 · Cited by 133 · see citing works

Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression

Kriegsman, B. A., Vangala, P., Chen, B. J., Meraner, P., Brass, A. L., Garber, M., & Rock, K. L. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900475 · Cited by 114 · see citing works

Distinct PD-L1/PD1 profiles and clinical implications in intrahepatic cholangiocarcinoma patients with different risk factors

Lu, J.-C., Zeng, H.-Y., Sun, Q.-M., Meng, Q.-N., Huang, X.-Y., Zhang, P.-F., Yang, X., Peng, R., Gao, C., Wei, C.-Y., et al. (2019) · Theranostics · doi:10.7150/thno.36276 · Cited by 72 · see citing works

Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy

Wang, Y., Ma, R., Liu, F., Lee, S. A., & Zhang, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00374 · Cited by 71 · see citing works

Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy

Ji, P., Sun, W., Zhang, S., Xing, Y., Wang, C., Wei, M., Li, Q., Ji, G., & Yang, G. (2023) · Advanced Science · doi:10.1002/advs.202301789 · Cited by 57 · see citing works

Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model

Padrón, Á., Hurez, V., Gupta, H. B., Clark, C. A., Pandeswara, S. L., Yuan, B., Svatek, R. S., Turk, M. J., Drerup, J. M., Li, R., et al. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.12.025 · Cited by 44 · see citing works

Research progress of T cells in cholangiocarcinoma

Wang, Z., Dai, Y., Zhou, Y., Wang, Y., Chen, P., Li, Y., Zhang, Y., Wang, X., Hu, Y., Li, H., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1453344 · Cited by 2 · see citing works

Wnt Signaling Regulates Hemopoiesis Through Stromal Cells

Yamane, T., Kunisada, T., Tsukamoto, H., Yamazaki, H., Niwa, H., Takada, S., & Hayashi, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.765 · Cited by 91 · see citing works

Rossette formation between stromal and hemopoietic cells: a simple assay for the supportive activity of stromal cells.

Aizawa, S., Hojo, H., Tsuda, A., et al. (1991) · PubMed · Cited by 8 · see citing works

[Radiosensitivity of stromal precursors and mature hematopoietic stromal cells in a culture].

Дризе, Н. И., Gurevich, O. A., & Chertkov, I. L. (1986) · PubMed · Cited by 1 · see citing works

Hemopoietic stromal precursors in long-term culture of bone marrow: I. Precursor characteristics, kinetics in culture, and dependence on quality of donor hemopoietic cells in chimeras.

Jl, C., Дризе, Н. И., Gurevitch, O. A., et al. (1983) · PubMed · Cited by 22 · see citing works

[The role of the thymus in regulating the stromal cells responsible for the transfer of the hemopoiesis-inducing microenvironment in stress].

Ed, G., Dygaĭ, A. M., Zaritskiĭ, A. I., et al. (1989) · PubMed · Cited by 2 · see citing works